These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2470777)

  • 21. Treatment of experimental allergic neuritis with nedocromil sodium.
    Seeldrayers PA; Yasui D; Weiner HL; Johnson D
    J Neuroimmunol; 1989 Dec; 25(2-3):221-6. PubMed ID: 2479661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of experimental allergic neuritis serum on normal rat peripheral nerve.
    Rosen JL; Brown MJ; Rostami A
    Pathobiology; 1990; 58(2):95-8. PubMed ID: 1694436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of experimental allergic neuritis in rats by in vivo treatment with monoclonal anti T cell antibodies.
    Strigård K; Olsson T; Larsson P; Holmdahl R; Klareskog L
    J Neurol Sci; 1988 Feb; 83(2-3):283-91. PubMed ID: 3258628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The B cell repertoire in experimental allergic neuritis involves multiple myelin proteins and GM1.
    Zhu J; Link H; Weerth S; Linington C; Mix E; Qiao J
    J Neurol Sci; 1994 Sep; 125(2):132-7. PubMed ID: 7528788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initiation and development of experimental autoimmune neuritis in Lewis rats is independent of the cytotoxic capacity of NKR-P1A+ cells.
    Yu S; Zhu Y; Chen Z; Alheim M; Ljungberg A; Zhu J
    J Neurosci Res; 2002 Mar; 67(6):823-8. PubMed ID: 11891797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention and therapy of experimental autoimmune neuritis by an antibody against T cell receptors-alpha/beta.
    Jung S; Krämer S; Schluesener HJ; Hünig T; Toyka K; Hartung HP
    J Immunol; 1992 Jun; 148(12):3768-75. PubMed ID: 1376340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuritogenic activity of peripheral nerve myelin proteins in Lewis rats.
    Suzuki M; Kitamura K; Uyemura K; Ogawa Y; Ishihara Y; Matsuyama H
    Neurosci Lett; 1980 Oct; 19(3):353-8. PubMed ID: 6189030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of peripheral tolerance with peptide-specific anergy in experimental autoimmune neuritis.
    Gregorian SK; Clark L; Heber-Katz E; Amento EP; Rostami A
    Cell Immunol; 1993 Sep; 150(2):298-310. PubMed ID: 7690307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis.
    Shi FD; Bai XF; Xiao BG; van der Meide PH; Link H
    J Neurol Sci; 1998 Feb; 155(1):1-12. PubMed ID: 9562316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of experimental autoimmune encephalomyelitis in Lewis rats by treatment with an anti-rat CD5 antibody (OX19).
    Sun D; Branum K; Sun Q
    Cell Immunol; 1992 Dec; 145(2):263-71. PubMed ID: 1280533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rolipram suppresses experimental autoimmune neuritis and prevents relapses in Lewis rats.
    Zou LP; Deretzi G; Pelidou SH; Levi M; Wahren B; Quiding C; van der Meide P; Zhu J
    Neuropharmacology; 2000 Jan; 39(2):324-33. PubMed ID: 10670428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental allergic neuritis. Humoral and cellular immune responses to the cyanogen bromide peptides of the P2 protein.
    Milek DJ; Cunningham JM; Powers JM; Brostoff SW
    J Neuroimmunol; 1983 Apr; 4(2):105-16. PubMed ID: 6187769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis.
    Tran GT; Hodgkinson SJ; Carter NM; Killingsworth M; Nomura M; Verma ND; Plain KM; Boyd R; Hall BM
    J Neuroimmunol; 2010 Dec; 229(1-2):98-106. PubMed ID: 20850187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The antibody repertoire in experimental allergic neuritis: evidence for PMP-22 as a novel neuritogen.
    Koehler NK; Martin R; Wiethölter H
    J Neuroimmunol; 1996 Dec; 71(1-2):179-89. PubMed ID: 8982118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cell vaccination does not induce resistance to experimental autoimmune neuritis.
    Jung S; Schluesener HJ; Toyka K; Hartung HP
    J Neuroimmunol; 1991 Dec; 35(1-3):1-11. PubMed ID: 1720130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of immune complexes in experimental allergic neuritis.
    Koh CS; Nakano T; Tsukada N; Yanagisawa N; Okano A; Taketomi T
    J Neurol Sci; 1984 Feb; 63(2):229-39. PubMed ID: 6368756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New minimum length requirement for a T cell epitope for experimental allergic neuritis.
    Olee T; Powell HC; Brostoff SW
    J Neuroimmunol; 1990 May; 27(2-3):187-90. PubMed ID: 1692033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune responses in experimental allergic neuritis.
    Hughes RA; Kadlubowski M; Gray IA; Leibowitz S
    J Neurol Neurosurg Psychiatry; 1981 Jul; 44(7):565-9. PubMed ID: 6974764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attempts to transfer experimental allergic neuritis with lymphocytes.
    Brosnan JV; Craggs RI; King RH; Thomas PK
    J Neuroimmunol; 1984; 6(6):373-85. PubMed ID: 6480819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P0 myelin protein produces experimental allergic neuritis in Lewis rats.
    Milner P; Lovelidge CA; Taylor WA; Hughes RA
    J Neurol Sci; 1987 Jul; 79(3):275-85. PubMed ID: 2440998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.